Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2015-11-11 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2015
Share Issue/Capital Change Classification · 99% confidence The document is titled "Company Announcement" and explicitly states that the company, Genmab A/S, will increase its share capital due to the exercise of employee warrants. It details the number of shares issued at various prices and the resulting change in total share capital. This action directly relates to changes in the company's capital structure and share issuance. According to the definitions, 'Share Issue/Capital Change (Code: SHA)' covers announcements regarding new share issues or capital changes. Although it involves warrants being exercised, the core event is the issuance of new shares and the resulting capital increase.
2015-11-11 English
Share Issue/Capital Change 2015
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a 'Capital Increase in Genmab as a Result of Employee Warrant Exercise'. It details the number of shares issued, the subscription prices, the total proceeds, and the resulting change in share capital. This activity directly relates to changes in the company's capital structure due to the exercise of employee stock options/warrants, which falls under the definition of 'Capital/Financing Update' (CAP). While it involves shares, it is not a general share issue (SHA) or a buyback (POS), but a specific financing/capital structure event resulting from employee compensation instruments.
2015-11-11 English
Legal Proceedings Report 2015
Legal Proceedings Report Classification · 99% confidence The document starts with "Selskabsmeddelelse" (Company Announcement) and details a specific corporate event: Genmab achieving a milestone payment of USD 3 million from Janssen related to the DuoBody platform, triggered by preclinical progress. This is a specific, time-sensitive update regarding a partnership and financial event, not a comprehensive annual report (10-K), a quarterly report (IR), or a general earnings release (ER). It is a specific corporate disclosure. Since it announces a financial/partnership development (milestone payment), it fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if no other category fits. Given the focus on receiving a specific payment and progress in a collaboration, 'CAP' (Capital/Financing Update) is a strong candidate, as milestone payments are financing/deal-related. However, in the context of regulatory filings, announcements of specific, non-routine corporate events that aren't earnings or major structural changes often fall under general regulatory announcements. Since 'CAP' covers fundraising/financing activities, and milestone payments are part of the financial structure of these deals, I will classify it as CAP. If CAP were not available, RNS would be the fallback. Given the nature of the announcement (milestone payment received), it is a specific financial/deal update.
2015-10-25 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 100% confidence The document is titled "Company Announcement" and details a specific business event: achieving a milestone payment in a collaboration with Janssen, triggering a $3 million payment. It provides context on the DuoBody technology and financial guidance impact. This type of announcement, which communicates a specific, non-periodic business development (like a partnership milestone or regulatory approval), typically falls under general Regulatory Filings (RNS) or, if it relates to financing/capital structure, CAP. Since this is a specific, material business event announcement that doesn't fit the definitions for ER, IR, or 10-K, and it's not a proxy statement (DEF 14A) or a management discussion (MDA), the most appropriate general category for a non-standard, material corporate update is Regulatory Filings (RNS). It is not a formal report (like 10-K or IR) nor a specific announcement like DIV or DIRS.
2015-10-25 English
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and specifically mentions "Storaktionærmeddelelse" (Major Shareholder Announcement). The content details that FIL Investments International (FMR LLC/Fidelity) has increased its indirect ownership stake in Genmab A/S to 10% as of October 22, 2015, referencing Danish Securities Law (Værdipapirlovens paragraf 29). This type of filing, which reports changes in significant share ownership crossing a threshold, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document length is short (3682 chars), but it is a direct notification of a transaction/holding change, not an announcement about the publication of a separate report.
2015-10-23 Danish
Major Shareholding Notification 2015
Major Shareholding Notification Classification · 99% confidence The document is titled "Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that FIL Investments International has informed Genmab that FMR LLC (Fidelity Management and Research) has increased its indirect ownership stake to 10% of the share capital, referencing Danish securities law (Værdipapirlovens paragraf 29). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The appropriate code is MRQ.
2015-10-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.